Bionano Symposium 2026 continues with Day 2: New Frontiers in Oncology and Bioprocessing Applications on February 24, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...
Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...
Good morning, and welcome to the Fulgent Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call. On the call are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; ...
News9Live on MSN
Repeated pregnancy loss: Expert says genetics may hold the key
A significant proportion of repeated pregnancy failures can be attributed to chromosomal abnormalities—either inherited from one of the parents or arising spontaneously in the embryo.
Background Balanced translocation (BT) carriers have a high risk of recurrent miscarriage and abnormal offspring due to unbalanced gamete production. Clinical genetic testing often fails to detect BTs ...
MINNEAPOLIS — With so many places offering Friday fish specials for Lent around the Twin Cities metro this year ... we're gonna need a bigger boat. We asked, and KARE 11 staff answered, sharing their ...
Enhancer hijacking emerges as a major “missing driver” mechanism in LBCL/PCN, enabling detection of non-chimeric oncogene activation such as IGL::BCL2, IGH::CCND2, and MAFA/MAFB rearrangements.
Fulgent Genetics Inc. reported its financial results for the fourth quarter of 2025, surpassing earnings per share (EPS) expectations but falling short on revenue. The company’s stock experienced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results